What this study is
The purpose of this study is to develop a culturally adapted contingency management (CM) protocol for Black adults with stimulant use disorder.
What's being tested
- Cultually Adapted Contingency Management (CM)
Intervention · BEHAVIORAL
Same protocol as basic CM with adaptations incorporated. The adaption will involve the ADAPT-ITT framework and PEN-3 cultural model.
- Basic Contingency Management (CM)
Intervention · BEHAVIORAL
An escalating schedule of reinforcement for submitting stimulant-negative urine at each clinic visit over the course of the 12 weeks
Study details
- Official title
- Cultural Adaptation of Contingency Management for Black Adults With Stimulant Use Disorder
- Sponsor
- Yale University
- Conditions
- Stimulant Use Disorders
- Enrolling
- 70 people
- Starts
- 2028-07
- Est. completion
- 2030-03
- Design
- Open-label, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 65 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Participants must self-identify as Black/African American
- DSM-5 diagnosis of stimulant use disorder in the past month (30 days)
You can't join if
- Individuals who are intoxicated or otherwise unable to provide consent
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openConnecticut Mental Health Center (CMHC)
New Haven, Connecticut, United States
Study team
Sponsor
Yale University
Study ID 2000040284
Principal investigator
Oluwole Jegede, MD, PhD
Yale University
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.